| Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels MA Sabin, M De Hora, JMP Holly, LP Hunt, AL Ford, SR Williams, ... Pediatrics 120 (6), e1426-e1433, 2007 | 69 | 2007 |
| The decision to discontinue screening for carnitine uptake disorder in New Zealand C Wilson, D Knoll, M de Hora, C Kyle, E Glamuzina, D Webster Journal of inherited metabolic disease 42 (1), 86-92, 2019 | 24 | 2019 |
| Measurement of 17-hydroxyprogesterone by LCMSMS improves newborn screening for CAH due to 21-hydroxylase deficiency in New Zealand MR de Hora, NL Heather, T Patel, LG Bresnahan, D Webster, PL Hofman International journal of neonatal screening 6 (1), 6, 2020 | 21 | 2020 |
| Evaluation of the revised New Zealand national newborn screening protocol for congenital hypothyroidism NL Heather, PL Hofman, M de Hora, J Carll, JGB Derraik, D Webster Clinical Endocrinology 86 (3), 431-437, 2017 | 20 | 2017 |
| The natural history of elevated tetradecenoyl‐L‐carnitine detected by newborn screening in New Zealand: implications for very long chain acyl‐CoA dehydrogenase deficiency … B Ryder, D Knoll, DR Love, P Shepherd, JM Love, PW Reed, M de Hora, ... Journal of Inherited Metabolic Disease: Official Journal of the Society for …, 2016 | 12 | 2016 |
| The risk of fatty acid oxidation disorders and organic acidemias in children with normal newborn screening C Wilson, D Knoll, M de Hora, C Kyle, E Glamuzina, D Webster JIMD Reports, Volume 35, 53-58, 2017 | 7 | 2017 |
| Implementing steroid profiling by liquid chromatography‐tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand MR de Hora, NL Heather, T Patel, LG Bresnahan, D Webster, PL Hofman Clinical Endocrinology 94 (6), 904-912, 2021 | 6 | 2021 |
| Birth Weight–or Gestational Age–adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand MR de Hora, NL Heather, D Webster, BB Albert, PL Hofman The Journal of Clinical Endocrinology & Metabolism 106 (9), e3390-e3399, 2021 | 4 | 2021 |
| Evaluation of a new laboratory protocol for newborn screening for congenital adrenal hyperplasia in New Zealand MR de Hora, NL Heather, DR Webster, BB Albert, PL Hofman International Journal of Neonatal Screening 8 (4), 56, 2022 | 3 | 2022 |
| Introducing Newborn Screening for Severe Combined Immunodeficiency—The New Zealand Experience N Heather, M de Hora, S Brothers, P Grainger, D Knoll, D Webster International Journal of Neonatal Screening 8 (2), 33, 2022 | 3 | 2022 |
| Introduction of a Protocol for Structured Follow-Up and Texting of Inadequate and Borderline-Positive Newborn Metabolic Screening Results N Heather, L Morgan, D Knoll, K Shore, M de Hora, D Webster International Journal of Neonatal Screening 8 (2), 30, 2022 | 2 | 2022 |
| The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives M de Hora, N Heather, D Webster, B Albert, P Hofman Frontiers in Endocrinology 14, 1226284, 2023 | 1 | 2023 |
| The risk of classical galactosaemia in newborns with borderline galactose metabolites on newborn screening I Bernhardt, E Glamuzina, B Ryder, D Knoll, N Heather, M De Hora, ... JIMD reports 64 (2), 180-186, 2023 | 1 | 2023 |
| Acknowledgment to Reviewers of International Journal of Neonatal Screening in 2020 International Journal of Neonatal Screening Editorial Office International Journal of Neonatal Screening 7 (1), 4, 2021 | 1 | 2021 |
| Newborn screening for congenital adrenal hyperplasia M de Hora, N Heather, D Webster, B Albert, P Hofman Pathology 55, S6, 2023 | | 2023 |
| The development of a rapid molecular assay for severe combined immunodeficiency (SCID) using dried blood spots SL Nickerson, PA Dryland, M de Hora, DR Love, D Webster Pathology 49, S31, 2017 | | 2017 |
| First steps in the harmonisation of adult plasma amino acid reference intervals in Australasia M de Hora, J Pitt, A Mishra, B Devanapalli, B McWhinney, A McWhinney, ... Pathology 48, S62, 2016 | | 2016 |
| Liquid chromatography mass spectrometry of 17-hydroxyprogesterone to improve screening for congenital adrenal hyperplasia in New Zealand M de Hora Pathology 48, S13, 2016 | | 2016 |
| Increased levels of myristate, palmitate and oleate predominantly account for the raised circulating non-esterified fatty acid (NEFA) levels seen in obese children MA Sabin, M De Hora, JMP Holly, AL Ford, SRP Williams, JS Baker, ... Obesity Reviews, 155-155, 2006 | | 2006 |
